Daniel Ryu
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
- Neurological disorders and treatments
- Neurological diseases and metabolism
-
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 9
-
- Parkinson's Disease Mechanisms and Treatments 4
- Neuroinflammation and Neurodegeneration Mechanisms 4
- Amyotrophic Lateral Sclerosis Research 1
- Neurological disorders and treatments 1
- Co-authors
- Todd E. Golde (10 shared papers)Benoit I. Giasson (7 shared papers)Paramita Chakrabarty (7 shared papers)Pedro E. Cruz (5 shared papers)Nikolaus R. McFarland (2 shared papers)Hyo‐Jin Park (2 shared papers)Mayur Parmar (2 shared papers)Marshall S. Goodwin (3 shared papers)
- Journals
- Alzheimer s & Dementia (3 papers)Nature Communications (1 paper)iScience (1 paper)Neurology (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Daniel Ryu
17 papers receiving 249 citations
Peers
Comparison fields: 5 of 58
- Neurology 70
- Neurology 82
- Physiology 99
- Biological Psychiatry 8
- Cellular and Molecular Neuroscience 54
Countries citing papers authored by Daniel Ryu
This map shows the geographic impact of Daniel Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ryu more than expected).
Fields of papers citing papers by Daniel Ryu
This network shows the impact of papers produced by Daniel Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ryu. The network helps show where Daniel Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 64 | |
| 2 | 2019 | 37 | |
| 3 | 2018 | 32 | |
| 4 | 2019 | 27 | |
| 5 | 2017 | 21 | |
| 6 | 2021 | 15 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2024 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 2018 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2022 | 1 | |
| 17 | Wind Shielding Estimation of a Vessel in Side by Side Configuration using Disturbed Velocity Field from CFD | 2018 | 1 |
About Daniel Ryu
Daniel Ryu is a scholar working on Physiology, Neurology, Cellular and Molecular Neuroscience, Neurology and Oncology, having authored 17 papers that have together received 252 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Cellular transport and secretion (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Neurological disorders and treatments (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Neurology (70 citations), Neurology (82 citations), Physiology (99 citations), Biological Psychiatry (8 citations) and Cellular and Molecular Neuroscience (54 citations). Daniel Ryu has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Todd E. Golde, Benoit I. Giasson, Paramita Chakrabarty, Pedro E. Cruz, Nikolaus R. McFarland, Hyo‐Jin Park, Mayur Parmar, Marshall S. Goodwin, David Borchelt and Dennis W. Dickson. Their work appears in journals such as Alzheimer s & Dementia, Nature Communications, iScience, Neurology and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.